dariohealth.investorroom.comDarioHealth | News for Investors

Our Story Clinical Research Careers Articles Diversity & Inclusion Our Solutions Metabolic Solutions Musculoskeletal Solutions Behavioral Health Solutions For Organizations Health Plans Employers Providers For Investors Events & Presentations Press Releases Corporate Governance Filings Stock Info Alerts FAQs Shop Dario Store Diabetes Hypertension Weight Memberships CONTACT US Events & PresentationsAbout DarioHealth DarioHealth Corp. (NASDAQ:DRIO) is a leading digital health company revolutionizing how people with chronic conditions manage their health through a user-centric multi-chronic condition digital therapeutics platform. Our platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. Our user-centric platform offers people continuous and customized care for health, disrupting the traditional episodic approach to healthcare. This approach empowers people to holistically adapt their lifestyles for sustainable behavior change, driving exceptional user satisfaction, retention, and results. Making the right thing to do the easy thing to do. Dario provides its highly user rated solutions globally to health plans and other payors, self-insured employers, providers of care and directly to consumers. To learn more about DarioHealth and its digital health solutions, or for more information, visit http://dariohealth.com . Our Mission We make it easy for people to care for their health, with continuous and connected support that anticipates needs, understands motivation, and simplifies behavior change to put better health and outcomes in everyone’s reach. DarioHealth Management Fireside Chat at 2024 Cowen Healthcare Conference Erez Raphael, CEO, and Rick Anderson, President, participated in a fireside chat at the Cowen Healthcare conference on March 6 th , 2024 where they discussed the latest developments at Dario. Topics include: Dario/Twill overview, Aetna launch, B2B growth, the market for multi-condition solutions, Winning new customers, GLP-1s, the Sanofi partnership and the 2024 outlook. Use the link below to access the replay: https://wsw.com/webcast/cowen154/drio/2016052 . Conference Call Announcing DarioHealth’s Acquisition of Twill Dario and Twill management hosted a conference call on February 21 st , 2024 announcing Dario’s strategic acquisition of Twill, a leader in digital-led care. The combination enables Dario to create one of the most comprehensive digital offerings in the market for chronic conditions, spanning a wide spectrum of health and well-being needs from emotional health to the costliest chronic conditions. The transaction creates immediate scale, with three of the top eight national health plans, multiple Fortune 100 employers and several major pharmaceutical companies as customers. Use these links to access the replay and transcript . DarioHealth Investor Day Presentation on October 17th 2023 DarioHealth hosted an Investor Day on October 17th, 2023 in NYC. In a discussion about the rise of digital health and the clinical research shaping its future, the Dario management team was joined by respected industry leaders including Arnaud Robert, respected technology expert and former head of digital for Sanofi and Nike, and Felix Lee, U.S. Digital Healthcare Medical Head, Sanofi U.S. A Dario client along with several members shared how these solutions are changing behaviors and improving health by delivering personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. Dario’s executive management team provided a deep dive into the company’s product and market growth plans and highlighted the full potential of the company’s user-centric, multi-chronic condition digital health platform. Hear what questions investors had for the team during the live Q&A session at the end of the presentation. Recent Press Releases Alerts May 7, 2024 DarioHealth to Report First Quarter 2024 Results on Wednesday, May 15th Apr 25, 2024 Dario Publishes New Peer-Reviewed Study that Deepens the Body of Evidence that Managing Cardiometabolic Conditions in One Integrated Platform Improves Clinical Outcomes Apr 18, 2024 Dario Signs Two Employers for Cardiometabolic Suite with Integrated GLP-1 Solution Recent News May 9, 2022 DarioHealth (DRIO) CMO Omar Manejwala highlights the value of an integrated approach | Managed Healthcare Executive May 2, 2022 DarioHealth (DRIO) President and GM, North America Rick Anderson talks about the growth of digital health | Yahoo March 2, 2022 DarioHealth (DRIO) and Sanofi ink $30 million agreement | MobiHealthNews January 5, 2022 DarioHealth (DRIO) CEO Erez Raphael on why digital therapeutics are transforming the market | TD Ameritrade Live December 16, 2021 DarioHealth (DRIO) CEO Erez Raphael interviewed on the innovative roots of Dario | McKinsey Health Tech Network November 12, 2021 Why we can’t afford to pretend telehealth is digital health | MobiHealthNews October 25, 2021 DarioHealth (DRIO) CEO Erez Raphael discusses product and client expansion | TDAmeritrade Network Live October 19, 2021 DarioHealth Launches MSK platform Dario Move | MobiHealthNews August 31, 2021 DarioHealth (DRIO) CEO Erez Raphael talks about digital therapeutics vs digital health | TDAmeritrade Network Live August 16, 2021 Can an app be medicine? These companies think so. | Fast Company Augut 9, 2021 In the feeding frenzy of health-tech deal-making, the little fish wield the power. | STAT Health May 24, 2021 DarioHealth (DRIO) CEO Erez Raphael Talks Earnings and wayForward Acquisition | TDAmeritrade Network Live May 18, 2021 DarioHealth (DRIO) Expands Mental Health Foothold with wayForward Acquisition | MobiHealthNews DarioHealth Investor Presentation DarioHealth Investor Presentation (5.1 MB) Quick Links Press Releases Investor Presentation Investor Day Video Recording Q4 and full year 2023 earnings call transcriptStock Data Subscribe For Alerts * Required Fields * Email Let’s get started To arrange a demo and learn more about the many benefits of offering Dario to your employees, members, or patients, contact us today. Get started Contact Us Follow Us Supported Devices Dario Support Toll-Free: 833-914-3796 © 2022 DarioHealth Corp. View our Privacy Policy or Terms and Conditions DarioHealth is a publicly traded company (Nasdaq: DRIO). Supported Devices iOS Application version – 4.3.1 Supported iOS phones (Audio Jack): iPhone 5, 5s, SE, 6, 6 Plus, 6s, 6s Plus Supported iOS phones (LC): 7, 7 Plus, 8, 8 Plus, X, Xs, Xs Max, XR, 11, 11 Pro, 11 Pro Max, SE 2020 iOS Operating System: 10, 11, 12, 13 (*) Note: iPhone7, 7 Plus, 8, 8 Plus, X, Xs, Xs Max, Xr are supported with the product Dario LC Blood Glucose Monitoring System. Android Application version – 4.5.0 Supported Android phones (Audio Jack): LG G6, G7, G8. Samsung Galaxy S6, S6 Edge, S7, S7 Edge, S8, S8+, S9, S9+, S10, S10+, S10e, S10 5G. Galaxy Note 4, 5, 8, 9 Supported Android phones (USB-C): LG G6, G7, G8. Samsung Galaxy S8, S8+, S9, S9+, S10, S10+, S10e, S10 5G, S20, S20+, S20 Ultra. Galaxy Note 8, 9, 10, 10+ Google Pixel 3, 3 XL, 4, 4 XL Android Operating System: 6, 7, 8, 9...